Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
Authors
Keywords
-
Journal
Frontiers in Chemistry
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-07
DOI
10.3389/fchem.2020.00571
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antibody–Prodrug Conjugates with KSP Inhibitors and Legumain‐Mediated Metabolite Formation
- (2019) Hans‐Georg Lerchen et al. CHEMISTRY-A EUROPEAN JOURNAL
- Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
- (2019) Jihye Yoo et al. Cancers
- Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era
- (2019) Minoru Suzuki International Journal of Clinical Oncology
- Antibody–drug conjugates for cancer
- (2019) Cindy H Chau et al. LANCET
- Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study
- (2019) Gilles R Dagenais et al. LANCET
- Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy
- (2019) Dennis J. Worm et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification and stabilization of a highly selective gastrin‐releasing peptide receptor agonist
- (2019) Paul Hoppenz et al. JOURNAL OF PEPTIDE SCIENCE
- A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy
- (2019) Paul Hoppenz et al. JOURNAL OF ORGANIC CHEMISTRY
- The Molecular Basis of G Protein–Coupled Receptor Activation
- (2018) William I. Weis et al. Annual Review of Biochemistry
- On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
- (2018) Eirinaios I Vrettos et al. Beilstein Journal of Organic Chemistry
- Peptide chemistry toolbox – Transforming natural peptides into peptide therapeutics
- (2018) Miloš Erak et al. BIOORGANIC & MEDICINAL CHEMISTRY
- GPCRs: Emerging anti-cancer drug targets
- (2018) Ainhoa Nieto Gutierrez et al. CELLULAR SIGNALLING
- Glutathione metabolism in cancer progression and treatment resistance
- (2018) Ankita Bansal et al. JOURNAL OF CELL BIOLOGY
- GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment
- (2018) Yan Zou et al. MOLECULAR PHARMACEUTICS
- G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
- (2018) Krishna Sriram et al. MOLECULAR PHARMACOLOGY
- Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents
- (2018) Minhee Kim et al. MOLECULES
- Advances in targeting the folate receptor in the treatment/imaging of cancers
- (2018) Marcos Fernández et al. Chemical Science
- Aptamers in the Therapeutics and Diagnostics Pipelines
- (2018) Harleen Kaur et al. Theranostics
- GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets
- (2018) Paul A. Insel et al. Frontiers in Pharmacology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A stable meta -carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor
- (2018) Dennis J. Worm et al. JOURNAL OF PEPTIDE SCIENCE
- The Role of Neuropeptide Y in Cardiovascular Health and Disease
- (2018) Cheryl M. J. Tan et al. Frontiers in Physiology
- Towards antibody-drug conjugates and prodrug strategies with extracellular stimuli-responsive drug delivery in the tumor microenvironment for cancer therapy
- (2017) Nicolas Joubert et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Marked for death: targeting epigenetic changes in cancer
- (2017) Sophia Xiao Pfister et al. NATURE REVIEWS DRUG DISCOVERY
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving radiotherapy in cancer treatment: Promises and challenges
- (2017) Helen H.W. Chen et al. Oncotarget
- The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis
- (2017) Carsten Gründker et al. Frontiers in Endocrinology
- A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
- (2017) Tobias G. Kapp et al. Scientific Reports
- Structure and function of legumain in health and disease
- (2016) Elfriede Dall et al. BIOCHIMIE
- Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery
- (2016) Y. Gilad et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells
- (2016) Y. Gilad et al. BIOPOLYMERS
- Charge-Compensated Metallacarborane Building Blocks for Conjugation with Peptides
- (2016) René Frank et al. CHEMBIOCHEM
- Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment
- (2016) Paola Moreno et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor
- (2016) Kathleen A. Fitzgerald et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging
- (2016) Hong-Jun Cho et al. JOURNAL OF CONTROLLED RELEASE
- Double Methotrexate-Modified Neuropeptide Y Analogues Express Increased Toxicity and Overcome Drug Resistance in Breast Cancer Cells
- (2016) David Böhme et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy
- (2016) E. Hindie et al. JOURNAL OF NUCLEAR MEDICINE
- Innovative chemical synthesis and conformational hints on the lipopeptide liraglutide
- (2016) Ivan Guryanov et al. JOURNAL OF PEPTIDE SCIENCE
- Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
- (2016) Heather Donaghy mAbs
- Small Molecules for Active Targeting in Cancer
- (2016) Chin S. Kue et al. MEDICINAL RESEARCH REVIEWS
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy
- (2016) Anna Szlachcic et al. Drug Design Development and Therapy
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model
- (2015) Yoshiya Iguchi et al. BIOMATERIALS
- Peptide Receptor Radionuclide Therapy: An Overview
- (2015) Ashutosh Dash et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Controlling Toxicity of Peptide-Drug Conjugates by Different Chemical Linker Structures
- (2015) David Böhme et al. ChemMedChem
- Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation
- (2015) Tetsuya Kadonosono et al. JOURNAL OF CONTROLLED RELEASE
- Smart linkers in polymer–drug conjugates for tumor-targeted delivery
- (2015) Minglu Chang et al. JOURNAL OF DRUG TARGETING
- Synthesis and in Vitro and in Vivo Evaluation of an 18F-Labeled Neuropeptide Y Analogue for Imaging of Breast Cancer by PET
- (2015) Sven Hofmann et al. MOLECULAR PHARMACEUTICS
- Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI
- (2015) Atefeh Jafari et al. NANOTECHNOLOGY
- Targeting the translation machinery in cancer
- (2015) Mamatha Bhat et al. NATURE REVIEWS DRUG DISCOVERY
- Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells
- (2015) Eric J. Rellinger et al. PEDIATRIC BLOOD & CANCER
- Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy
- (2015) Micah John Luderer et al. PHARMACEUTICAL RESEARCH
- GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
- (2015) Fan Pu et al. Scientific Reports
- Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy
- (2015) Anna Barbuti et al. Cancers
- Immunogenicity of Antibody Drug Conjugates: Bioanalytical Methods and Monitoring Strategy for a Novel Therapeutic Modality
- (2014) M. Benjamin Hock et al. AAPS Journal
- Automated solid-phase peptide synthesis to obtain therapeutic peptides
- (2014) Veronika Mäde et al. Beilstein Journal of Organic Chemistry
- The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide
- (2014) Hiroyuki Michiue et al. BIOMATERIALS
- A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors
- (2014) Hiroshi Wakui et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Receptor-Mediated Uptake of Boron-Rich Neuropeptide Y Analogues for Boron Neutron Capture Therapy
- (2014) Verena M. Ahrens et al. ChemMedChem
- Targeted Chemotherapy with Metal Complexes
- (2014) Alyson G. Weidmann et al. COMMENTS ON INORGANIC CHEMISTRY
- Vasoactive intestinal peptide receptor-based imaging and treatment of tumors
- (2014) BO TANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Controlled release of free doxorubicin from peptide–drug conjugates by drug loading
- (2014) Zhipeng Chen et al. JOURNAL OF CONTROLLED RELEASE
- Cell-Penetrating, Guanidinium-Rich Molecular Transporters for Overcoming Efflux-Mediated Multidrug Resistance
- (2014) Jessica R. Vargas et al. MOLECULAR PHARMACEUTICS
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- 1,2,3-Triazoles as Amide Bond Mimics: Triazole Scan Yields Protease-Resistant Peptidomimetics for Tumor Targeting
- (2013) Ibai E. Valverde et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells
- (2013) Scott H. Medina et al. BIOMATERIALS
- Acidic extracellular microenvironment and cancer
- (2013) Yasumasa Kato et al. Cancer Cell International
- Phase I Study of GRN1005 in Recurrent Malignant Glioma
- (2013) J. Drappatz et al. CLINICAL CANCER RESEARCH
- An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
- (2013) Zilin Yu et al. CURRENT PHARMACEUTICAL DESIGN
- Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents
- (2013) Hala Bakr El-Nassan EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cathepsin B as a cancer target
- (2013) Christopher S Gondi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment
- (2013) Hoang Hanh Phuoc Duong et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tunable Thioesters as “Reduction” Responsive Functionality for Traceless Reversible Protein PEGylation
- (2013) Jianwei Chen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases
- (2013) Mazen Jamous et al. MOLECULES
- Targeting GRPR in urological cancers—from basic research to clinical application
- (2013) Rosalba Mansi et al. Nature Reviews Urology
- Immunogenicity assays for antibody–drug conjugates: case study with ado-trastuzumab emtansine
- (2013) Montserrat Carrasco-Triguero et al. Bioanalysis
- A review of the use of somatostatin analogs in oncology
- (2013) Suayib Yalcin et al. OncoTargets and Therapy
- Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy
- (2013) Zherui Wu et al. Frontiers in Endocrinology
- Neuropeptide Y receptors: how to get subtype selectivity
- (2013) Xavier Pedragosa-Badia et al. Frontiers in Endocrinology
- Targeted delivery of doxorubicin through conjugation with EGF receptor-binding peptide overcomes drug resistance in human colon cancer cells
- (2012) Shibin Ai et al. BRITISH JOURNAL OF PHARMACOLOGY
- Disulfide Linkage: A Potent Strategy in Tumor-Targeting Drug Discovery
- (2012) J. Wang et al. CURRENT MEDICINAL CHEMISTRY
- Converting Peptides into Drug Leads by Lipidation
- (2012) L. Zhang et al. CURRENT MEDICINAL CHEMISTRY
- GnRH Receptors in Cancer: From Cell Biology to Novel Targeted Therapeutic Strategies
- (2012) Patrizia Limonta et al. ENDOCRINE REVIEWS
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Peptides and peptide conjugates: therapeutics on the upward path
- (2012) Verena M Ahrens et al. Future Medicinal Chemistry
- Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent
- (2012) Giancarlo Morelli et al. International Journal of Nanomedicine
- Targeted drug delivery for cancer therapy: the other side of antibodies
- (2012) Michael A Firer et al. Journal of Hematology & Oncology
- Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(iv)–peptide bioconjugates
- (2012) Luca Gaviglio et al. Metallomics
- Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
- (2012) Rolf F Barth et al. Radiation Oncology
- Integrin Targeted Delivery of Chemotherapeutics
- (2012) Kai Chen et al. Theranostics
- Smart Nanocarrier Based on PEGylated Hyaluronic Acid for Cancer Therapy
- (2011) Ki Young Choi et al. ACS Nano
- Prodrug-based intracellular delivery of anticancer agents
- (2011) L. Bildstein et al. ADVANCED DRUG DELIVERY REVIEWS
- Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy
- (2011) Sadaaki Kimura et al. BIOORGANIC & MEDICINAL CHEMISTRY
- NPY receptors as potential targets for anti-obesity drug development
- (2011) Ernie Yulyaningsih et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
- (2011) Matthias Scholz et al. CHEMICAL REVIEWS
- Yttrium-90 (90Y) in the principal radionuclide therapies: An efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999–2009)
- (2011) Veronica Goffredo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals
- (2011) Sibaprasad Bhattacharyya et al. DALTON TRANSACTIONS
- Incorporation ofortho-Carbaboranyl-Nε-Modifiedl-Lysine into Neuropeptide Y Receptor Y1- and Y2-Selective Analogues
- (2011) Verena M. Ahrens et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers
- (2011) Carsten Gr�ndker ONCOLOGY REPORTS
- Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs
- (2011) Hirotsugu Uehara et al. PEPTIDES
- The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancer
- (2011) Lei Zhang et al. PHARMACOLOGY & THERAPEUTICS
- Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states
- (2011) Nieves Gonzalez et al. Current Opinion in Endocrinology Diabetes and Obesity
- Breast-Cancer Diagnosis by Neuropeptide Y Analogues: From Synthesis to Clinical Application
- (2010) Irfan U. Khan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential
- (2010) K Sköld et al. BRITISH JOURNAL OF RADIOLOGY
- Insertion of a Lysosomal Enzyme Cleavage Site into the Sequence of a Radiolabeled Neuropeptide Influences Cell Trafficking In Vitro and In Vivo
- (2010) Syed Ali Raza Naqvi et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- The Legumain Protease-Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis without Toxicity
- (2010) Krishna Mohan Bajjuri et al. ChemMedChem
- Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept
- (2010) C. Falciani et al. CURRENT CANCER DRUG TARGETS
- Therapeutic potential of neuropeptide Y (NPY) receptor ligands
- (2010) Shaun P. Brothers et al. EMBO Molecular Medicine
- A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patients
- (2010) Pauline A. van Schouwenburg et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Integrins as therapeutic targets: lessons and opportunities
- (2010) Dermot Cox et al. NATURE REVIEWS DRUG DISCOVERY
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- Bombesin Receptor-Mediated Imaging and Cytotoxicity: Review and Current Status
- (2010) Veronica Sancho et al. Current Drug Delivery
- Somatostatin Receptor-Targeted Anti-Cancer Therapy
- (2010) Li-Chun Sun et al. Current Drug Delivery
- Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition
- (2009) Stephan Seitz et al. ANTI-CANCER DRUGS
- Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents
- (2009) W. Yang et al. APPLIED RADIATION AND ISOTOPES
- A Novel Antitumor Prodrug Platform Designed to Be Cleaved by the Endoprotease Legumain
- (2009) Liron Stern et al. BIOCONJUGATE CHEMISTRY
- Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
- (2009) Laurent Ducry et al. BIOCONJUGATE CHEMISTRY
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
- (2009) Kazuki N. Sugahara et al. CANCER CELL
- Synthetic therapeutic peptides: science and market
- (2009) Patrick Vlieghe et al. DRUG DISCOVERY TODAY
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- (2009) Dik J Kwekkeboom et al. ENDOCRINE-RELATED CANCER
- Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors
- (2009) Weilian Yang et al. JOURNAL OF NEURO-ONCOLOGY
- First selective agonist of the neuropeptide Y1-receptor with reduced size
- (2009) Denise Zwanziger et al. JOURNAL OF PEPTIDE SCIENCE
- Molecular imaging targeting peptide receptors
- (2009) Margret Schottelius et al. METHODS
- Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues
- (2009) R.P.J. Schroeder et al. METHODS
- The structure and function of G-protein-coupled receptors
- (2009) Daniel M. Rosenbaum et al. NATURE
- Peptide-receptor radionuclide therapy for endocrine tumors
- (2009) Martijn van Essen et al. Nature Reviews Endocrinology
- Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
- (2008) Shuang Liu ADVANCED DRUG DELIVERY REVIEWS
- closo-Borane Conjugated Regulatory Peptides Retain High Biological Affinity: Synthesis ofcloso-Borane Conjugated Tyr3-Octreotate Derivatives for BNCT
- (2008) Thomas Betzel et al. BIOCONJUGATE CHEMISTRY
- In Vitroandin VivoEvaluation of Doxorubicin Conjugates with the Divalent Peptide E-[c(RGDfK)2] that Targets Integrin αvβ3
- (2008) Claudia Ryppa et al. BIOCONJUGATE CHEMISTRY
- Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2
- (2008) A Régina et al. BRITISH JOURNAL OF PHARMACOLOGY
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- The epidermal growth factor receptor family: Biology driving targeted therapeutics
- (2008) M. J. Wieduwilt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Molecular Targeting and Treatment of Composite EGFR and EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibodies
- (2008) W. Yang et al. CLINICAL CANCER RESEARCH
- High Expression of Neuropeptide Y1 Receptors in Ewing Sarcoma Tumors
- (2008) M. Korner et al. CLINICAL CANCER RESEARCH
- Peptide-targeted radionuclide therapy for melanoma
- (2008) Yubin Miao et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Recent Progress in the Identification and Clinical Evaluation of Inhibitors of the Mitotic Kinesin KSP
- (2008) Steven Knight et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Paclitaxel–octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice
- (2008) Hongchang Shen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis
- (2008) Michael Vibo Grandal et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting
- (2008) R. Cescato et al. JOURNAL OF NUCLEAR MEDICINE
- International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
- (2008) R. T. Jensen et al. PHARMACOLOGICAL REVIEWS
- The Synthesis and Chelation Chemistry of DOTA−Peptide Conjugates
- (2007) Luis M. De León-Rodríguez et al. BIOCONJUGATE CHEMISTRY
- Prodrug Strategies in Anticancer Chemotherapy
- (2007) Felix Kratz et al. ChemMedChem
- Somatostatin, cortistatin and their receptors in tumours
- (2007) M. Volante et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now